Stay updated on Cabozantinib in Salivary Gland Cancer: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.

Latest updates to the Cabozantinib in Salivary Gland Cancer: Clinical Trial page
- Check5 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2; the page otherwise remains a 403 error screen.SummaryDifference0.2%

- Check12 days agoChange DetectedThe footer site revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with a simple error screen and minimal navigation.SummaryDifference19%

- Check54 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a small update to the site's underlying content or scripts. No substantive study information or functionality appears to be changed.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now displays a generic error page (HTTP 500) instead of the study record content, indicating the page is temporarily unavailable.SummaryDifference18%

- Check90 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page. This indicates a new release of the study record, reflecting a minor update to the page's metadata.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Salivary Gland Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.